300 related articles for article (PubMed ID: 15756429)
21. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.
Miyadera K; Sumizawa T; Haraguchi M; Yoshida H; Konstanty W; Yamada Y; Akiyama S
Cancer Res; 1995 Apr; 55(8):1687-90. PubMed ID: 7536129
[TBL] [Abstract][Full Text] [Related]
22. The cytosol activity of thymidine phosphorylase in endometrial cancer.
Miszczak-Zaborska E; Kubiak R; Bieńkiewicz A; Bartkowiak J
J Exp Clin Cancer Res; 2008 Nov; 27(1):64. PubMed ID: 18986516
[TBL] [Abstract][Full Text] [Related]
23. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma.
Fujieda S; Sunaga H; Tsuzuki H; Tanaka N; Saito H
Clin Cancer Res; 1998 Jul; 4(7):1583-90. PubMed ID: 9676830
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
25. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
[TBL] [Abstract][Full Text] [Related]
26. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
[TBL] [Abstract][Full Text] [Related]
27. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
28. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
[TBL] [Abstract][Full Text] [Related]
29. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
Jin-no K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Endo H; Doi T; Mandai K; Ishitsuka H
Cancer; 1998 Apr; 82(7):1260-7. PubMed ID: 9529017
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate.
Okada K; Yokoyama K; Okihara K; Ukimura O; Kojima M; Miki T; Takamatsu T
Urology; 2001 Feb; 57(2):376-81. PubMed ID: 11182368
[TBL] [Abstract][Full Text] [Related]
31. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
[TBL] [Abstract][Full Text] [Related]
32. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.
Igawa H; Fujieda S; Kimura Y; Sugimoto C; Tanaka N; Ohtsubo T; Kato Y; Saito H
Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754
[TBL] [Abstract][Full Text] [Related]
33. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer.
Tanaka T; Yoshiki T; Arai Y; Higuchi K; Kageyama S; Ogawa Y; Isono T; Okada Y
Jpn J Cancer Res; 1999 Dec; 90(12):1344-50. PubMed ID: 10665652
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast.
Engels K; Fox SB; Whitehouse RM; Gatter KC; Harris AL
J Pathol; 1997 Aug; 182(4):414-20. PubMed ID: 9306962
[TBL] [Abstract][Full Text] [Related]
35. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer.
Nagaoka H; Iino Y; Takei H; Morishita Y
Int J Oncol; 1998 Sep; 13(3):449-54. PubMed ID: 9683777
[TBL] [Abstract][Full Text] [Related]
36. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived endothelial cell growth factor gene therapy for limb ischemia.
Yamada N; Li W; Ihaya A; Kimura T; Morioka K; Uesaka T; Takamori A; Handa M; Tanabe S; Tanaka K
J Vasc Surg; 2006 Dec; 44(6):1322-8. PubMed ID: 17145437
[TBL] [Abstract][Full Text] [Related]
38. The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion.
Takahashi Y; Ellis LM; Mai M
Oncol Rep; 2003; 10(1):9-13. PubMed ID: 12469136
[TBL] [Abstract][Full Text] [Related]
39. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Terao T
Hum Pathol; 2002 Nov; 33(11):1105-13. PubMed ID: 12454815
[TBL] [Abstract][Full Text] [Related]
40. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
